Circular RNAs in Metabolic Diseases.

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• Metabolic diseases, including diabetes mellitus (DM) and non-alcoholic fatty liver disease (NAFLD), represent a significant global health burden.
• Circular RNAs (circRNAs) are distinct RNA molecules with a closed-loop structure, differing from linear RNAs.
• The functional roles of circRNAs in metabolic diseases remain largely underexplored, with limited existing research.

Purpose of the Study:

• To review the epidemiology, pathophysiology, and treatment of DM and NAFLD.
• To elucidate the relationship between circRNAs and the development or progression of DM and NAFLD.
• To discuss emerging applications of circRNAs in molecular diagnostics, nucleic acid therapy, and as biomarkers for metabolic disorders.

Main Methods:

• Literature review of epidemiological data, pathophysiological mechanisms, and therapeutic strategies for DM and NAFLD.
• Analysis of current research on the involvement of circRNAs in metabolic diseases.
• Synthesis of recent findings on circRNA functions and potential clinical applications.

Main Results:

• A growing body of evidence suggests a significant role for circRNAs in the pathogenesis of DM and NAFLD.
• Specific circRNAs have been identified as potential regulators of metabolic processes.
• CircRNAs show promise as novel biomarkers and therapeutic targets for metabolic diseases.

Conclusions:

• Circular RNAs represent a critical, yet understudied, area in metabolic disease research.
• Understanding circRNA mechanisms offers new avenues for diagnosing and treating conditions like DM and NAFLD.
• Further investigation into circRNAs is warranted to fully harness their therapeutic and diagnostic potential.